26 related articles for article (PubMed ID: 2449247)
1. Detection of gangliosides as N-glycolylneuraminic acid-specific tumor-associated Hanganutziu-Deicher antigen in human retinoblastoma cells.
Higashi H; Sasabe T; Fukui Y; Maru M; Kato S
Jpn J Cancer Res; 1988 Aug; 79(8):952-6. PubMed ID: 2460424
[TBL] [Abstract][Full Text] [Related]
2. Endowing self-binding feature restores the activities of a loss-of-function chimerized anti-GM2 antibody.
Zhao Y; Russ M; Retter M; Fanger G; Morgan C; Kohler H; Muller S
Cancer Immunol Immunother; 2007 Feb; 56(2):147-54. PubMed ID: 16896968
[TBL] [Abstract][Full Text] [Related]
3. Chemical Synthesis of GM2 Glycans, Bioconjugation with Bacteriophage Qβ, and the Induction of Anticancer Antibodies.
Yin Z; Dulaney S; McKay CS; Baniel C; Kaczanowska K; Ramadan S; Finn MG; Huang X
Chembiochem; 2016 Jan; 17(2):174-80. PubMed ID: 26538065
[TBL] [Abstract][Full Text] [Related]
4. Involvement of a non-human sialic Acid in human cancer.
Samraj AN; Läubli H; Varki N; Varki A
Front Oncol; 2014; 4():33. PubMed ID: 24600589
[TBL] [Abstract][Full Text] [Related]
5. Metabolism of vertebrate amino sugars with N-glycolyl groups: resistance of α2-8-linked N-glycolylneuraminic acid to enzymatic cleavage.
Davies LR; Pearce OM; Tessier MB; Assar S; Smutova V; Pajunen M; Sumida M; Sato C; Kitajima K; Finne J; Gagneux P; Pshezhetsky A; Woods R; Varki A
J Biol Chem; 2012 Aug; 287(34):28917-31. PubMed ID: 22692207
[TBL] [Abstract][Full Text] [Related]
6. beta 1-4N-acetylgalactosaminyltransferase can synthesize both asialoglycosphingolipid GM2 and glycosphingolipid GM2 in vitro and in vivo: isolation and characterization of a beta 1-4N-acetylgalactosaminyltransferase cDNA clone from rat ascites hepatoma cell line AH7974F.
Hidari JK; Ichikawa S; Furukawa K; Yamasaki M; Hirabayashi Y
Biochem J; 1994 Nov; 303 ( Pt 3)(Pt 3):957-65. PubMed ID: 7980468
[TBL] [Abstract][Full Text] [Related]
7. Regulation of GM2 ganglioside metabolism in cultured cells.
Dawson G; Hancock LW; Vartanian T
Chem Phys Lipids; 1986 Dec; 42(1-3):105-16. PubMed ID: 3549015
[TBL] [Abstract][Full Text] [Related]
8. Human IgM antibody therapy for HIV-1 infection.
Okada N; Okada H
Microbiol Immunol; 1999; 43(8):729-36. PubMed ID: 10524789
[No Abstract] [Full Text] [Related]
9. Specific expression of unusual GM2 ganglioside with Hanganutziu-Deicher antigen activity on human colon cancers.
Hirabayashi Y; Kasakura H; Matsumoto M; Higashi H; Kato S; Kasai N; Naiki M
Jpn J Cancer Res; 1987 Mar; 78(3):251-60. PubMed ID: 3106281
[TBL] [Abstract][Full Text] [Related]
10. Production of monoclonal antibodies directed to Hanganutziu-Deicher active gangliosides, N-glycolylneuraminic acid-containing gangliosides.
Watarai S; Kushi Y; Shigeto R; Misawa N; Eishi Y; Handa S; Yasuda T
J Biochem; 1995 May; 117(5):1062-9. PubMed ID: 8586620
[TBL] [Abstract][Full Text] [Related]
11. Two chicken monoclonal antibodies specific for heterophil Hanganutziu-Deicher antigens.
Asaoka H; Nishinaka S; Wakamiya N; Matsuda H; Murata M
Immunol Lett; 1992 Mar; 32(1):91-6. PubMed ID: 1379980
[TBL] [Abstract][Full Text] [Related]
12. Generation of murine monoclonal antibodies specific for N-glycolylneuraminic acid-containing gangliosides.
Ozawa H; Kawashima I; Tai T
Arch Biochem Biophys; 1992 May; 294(2):427-33. PubMed ID: 1567198
[TBL] [Abstract][Full Text] [Related]
13. Characterization of N-glycolylneuraminic acid-containing gangliosides as tumor-associated Hanganutziu-Deicher antigen in human colon cancer.
Higashi H; Hirabayashi Y; Fukui Y; Naiki M; Matsumoto M; Ueda S; Kato S
Cancer Res; 1985 Aug; 45(8):3796-802. PubMed ID: 3874688
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibody directed to a Hanganutziu-Deicher active ganglioside, GM2 (NeuGc).
Sanai Y; Yamasaki M; Nagai Y
Biochim Biophys Acta; 1988 Feb; 958(3):368-74. PubMed ID: 2449247
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
